Tag: Haruo Naito

Eisai, Biogen secure Leqembi FDA accelerated approval for Alzheimer’s disease

Eisai and Biogen have secured the approval of the US Food and Drug Administration (FDA) for their jointly developed Leqembi (lecanemab-irmb) under the accelerated approval ... Read More